Guardian Wealth Advisors (North Carolina)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $468K | Sell |
1,052
-24
| -2% | -$10.7K | 0.03% | 205 |
|
2025
Q1 | $521K | Buy |
1,076
+14
| +1% | +$6.78K | 0.04% | 187 |
|
2024
Q4 | $427K | Buy |
1,062
+17
| +2% | +$6.84K | 0.03% | 206 |
|
2024
Q3 | $486K | Hold |
1,045
| – | – | 0.05% | 168 |
|
2024
Q2 | $490K | Sell |
1,045
-8
| -0.8% | -$3.75K | 0.06% | 160 |
|
2024
Q1 | $440K | Buy |
1,053
+24
| +2% | +$10K | 0.05% | 174 |
|
2023
Q4 | $418K | Sell |
1,029
-31
| -3% | -$12.6K | 0.06% | 155 |
|
2023
Q3 | $368K | Buy |
1,060
+13
| +1% | +$4.52K | 0.06% | 157 |
|
2023
Q2 | $368K | Buy |
1,047
+25
| +2% | +$8.79K | 0.06% | 154 |
|
2023
Q1 | $322K | Sell |
1,022
-32
| -3% | -$10.1K | 0.06% | 164 |
|
2022
Q4 | $304K | Hold |
1,054
| – | – | 0.06% | 152 |
|
2022
Q3 | $305K | Buy |
1,054
+32
| +3% | +$9.26K | 0.06% | 146 |
|
2022
Q2 | $288K | Buy |
1,022
+7
| +0.7% | +$1.97K | 0.05% | 151 |
|
2022
Q1 | $265K | Buy |
+1,015
| New | +$265K | 0.11% | 134 |
|